FlandersBio on Twitter

Follow us on Twitter

Archive for August 2012 - News

Archive for August 2012 - Nieuws

in het nederlands in english

FlandersBio informs you about important regional and national life sciences news. Send us your news. If your news is of interest to the life sciences community, we will post it on our website.

FlandersBio informeert u over belangrijk nieuws op het vlak van de biowetenschappen. Bezorg ons jouw nieuwtjes. Als het interessant is voor de sector, zullen wij het op onze website plaatsen.

Too much protein HUWE1 causes intellectual disability


2 to 3 % of the children are born with an intellectual disability. Possibly by a genetic defect, but in 80% of these cases, we do not know – yet - which genes are responsible. VIB researchers at KU Leuven show that increased production of the HUWE1 protein is the cause in some patients. read more

ThromboGenics NV - Business Update


ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on developing innovative ophthalmic medicines, today issued a business update and its financial results for the six-month period ending 30 June 2012. read more

MDxHealth Reports 2012 First-Half Results


MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, announced today its 2012 first half results. read more



read more

Devgen reports half year results 2012


Devgen nv (Euronext Brussels: DEVG), the agro-biotech company that shapes the field of hybrid rice in India and Southeast Asia and innovates in crop protection technologies, today provides a business update and its financial results for the first half of 2012. read more

Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis


Leuven scientists (VIB/KU Leuven) are using zebrafish as a model in their search for genes that play a role in the mechanism of amyotrophic lateral sclerosis (ALS). As a result, they have identified a molecule that could be the target for a future ALS treatment. ALS is a progressive degenerative motor neuron disease for which there currently is no treatment. Their study has been published in the prestigious journal Nature Medicine. read more

Promethera - Shortlisted for the EuropaBio Most Innovative EU Biotech SME Award 2012


Who are Europe's 5 most innovative biotech SMEs? EuropaBio has announced the top five candidates that will compete for the Most Innovative EU Biotech SME Award 2012. Now in its 3rd year, this year’s award has seen the highest number of entries to date with 37 applicants from across 17 Member States, operating in all three sectors of biotechnology from healthcare to industrial to agriculture. read more

Join E-news

Interested in a regular update of the life sciences and biotech sector in Flanders? Subscribe to our newsletter.

Subscribe now

Back to top